• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SOLTA MEDICAL INC. THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES; ELECTROSURGICAL,CUTTING & COAGULATION & ACC.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SOLTA MEDICAL INC. THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES; ELECTROSURGICAL,CUTTING & COAGULATION & ACC. Back to Search Results
Model Number TT4.00F6-900
Device Problems Improper or Incorrect Procedure or Method (2017); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Information (3190)
Patient Problem Burn(s) (1757)
Event Date 12/30/2019
Event Type  Injury  
Manufacturer Narrative
The treatment tip and treatment data log were returned for evaluation.Based on the evaluation of the data, the system and hand-piece perform as expected.The evaluation of the treatment tip indicates that the tip passed both visual inspection and thermistor testing however it failed the leak test.No functional testing was possible due to the tip being expired.A review of the device history record is in progress.Based on all available information, no causal factors can be determined and no conclusion can be drawn.
 
Event Description
A physician reported that a burn was observed on the right forehead following a thermage treatment across the face and neck.The patient was treated with percocet and xanax tablets before undergoing the procedure.Following the procedure, once the patient returned home, they observed a burn on the right forehead and subsequent scabbing has occurred.The patient was treated in office with oxygen and given triamcinolone and aquaphor to apply to the affected area.The physician also noted that the patient underwent a dysport injection treatment in the same area two weeks prior to the thermage treatment.The physician indicated that they inspected the treatment tip before and during treatment with no abnormalities observed.The treatment was completed at a max power level of 3.5.The physician noted that they used ample coupling fluid throughout the treatment.During treatment there was an issue with the coolant canister not filling properly leading to a tip too warm error code.The treatment tip and canister were swapped out following the error code and the treatment was completed with no additional issues.
 
Manufacturer Narrative
Correction to h4 a review of the manufacturing records showed all requirements were met.The treatment tip and datacard log were returned for evaluation.Evaluation of the treatment tip found no issues related to the event.Based on the evaluation of the data, the system and handpiece performed as expected.Service found errors were most likely technique related.Tip too warm error places the system into a safe state and presents no patent risk.Based on the available information, burns are a known possible side effects during thermage flx treatment.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMAGE FLX (TG-3A) SYSTEM AND ACCESSORIES
Type of Device
ELECTROSURGICAL,CUTTING & COAGULATION & ACC.
Manufacturer (Section D)
SOLTA MEDICAL INC.
11720 north creek pkwy n
suite 100
bothell WA 98011
MDR Report Key9652617
MDR Text Key185891152
Report Number3011423170-2020-00016
Device Sequence Number1
Product Code GEI
Combination Product (y/n)Y
PMA/PMN Number
K170758
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 01/01/2005,01/02/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberTT4.00F6-900
Device Catalogue NumberTT4.00F6-900
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/08/2020
Was the Report Sent to FDA? Yes
Date Report Sent to FDA01/01/2005
Date Report to Manufacturer01/10/2005
Initial Date Manufacturer Received 01/02/2020
Initial Date FDA Received01/31/2020
Supplement Dates Manufacturer Received05/19/2020
Supplement Dates FDA Received06/17/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-